Growth Metrics

Tango Therapeutics (TNGX) Current Assets (2020 - 2025)

Historic Current Assets for Tango Therapeutics (TNGX) over the last 6 years, with Q3 2025 value amounting to $163.8 million.

  • Tango Therapeutics' Current Assets fell 4555.49% to $163.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $163.8 million, marking a year-over-year decrease of 4555.49%. This contributed to the annual value of $266.3 million for FY2024, which is 2314.18% down from last year.
  • Latest data reveals that Tango Therapeutics reported Current Assets of $163.8 million as of Q3 2025, which was down 4555.49% from $190.1 million recorded in Q2 2025.
  • In the past 5 years, Tango Therapeutics' Current Assets registered a high of $516.3 million during Q3 2021, and its lowest value of $734293.0 during Q2 2021.
  • For the 5-year period, Tango Therapeutics' Current Assets averaged around $310.1 million, with its median value being $343.0 million (2023).
  • Its Current Assets has fluctuated over the past 5 years, first skyrocketed by 5928841.85% in 2022, then tumbled by 4555.49% in 2025.
  • Tango Therapeutics' Current Assets (Quarter) stood at $492.3 million in 2021, then decreased by 23.78% to $375.3 million in 2022, then fell by 7.66% to $346.5 million in 2023, then decreased by 23.14% to $266.3 million in 2024, then tumbled by 38.51% to $163.8 million in 2025.
  • Its Current Assets was $163.8 million in Q3 2025, compared to $190.1 million in Q2 2025 and $224.9 million in Q1 2025.